One stock that's trending very close to triggering a major breakout trade is
(SGEN - Get Report)
, which develops and commercializes monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. This stock has been a monster winner for the bulls so far in 2013, with shares up 57%.
If you take a look at the chart for Seattle Genetics, you'll notice that this stock has been uptrending strong for the last two months, with shares soaring higher from its low of $26.60 to its recent high of $37.64 a share. During that uptrend, shares of SGEN have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of SGEN within range of triggering a major breakout trade.
>>5 Health Care Stocks Under $10 Ready to Rip Higher
Traders should now look for long-biased trades in SGEN if it manages to break out above some near-term overhead resistance levels at $37 to $37.64 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 822,000 shares. If that breakout triggers soon, then SGEN will set up to enter new 52-week-high territory above $37.64, which is bullish technical price action. Some possible upside targets off that breakout are $40 to $45 a share or even $50 a share.
Traders can look to buy SGEN off any weakness to anticipate that breakout and simply use a stop that sits just below some key near-term support levels at $34.91 to $33.60 a share. One could also buy SGEN off strength once it takes out those breakout levels with volume and then simply use a stop just below $36 to $35 a share.